Preprocedural High-Sensitivity C-Reactive Protein Predicts Contrast-Induced Nephropathy and Long-Term Outcome After

Xiao-Sheng Guo1, Kai-Yang Lin1,2, Hua-Long Li1

  • 11 Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

Angiology
|November 5, 2016
PubMed

Insights

High-sensitivity C-reactive protein (hsCRP) predicts contrast-induced nephropathy (CIN) after coronary angiography (CAG). Elevated hsCRP levels also indicate a higher risk of long-term mortality in these patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarkers

Background:

  • Contrast-induced nephropathy (CIN) is a significant complication following coronary angiography (CAG).
  • Identifying reliable predictors of CIN and long-term outcomes is crucial for patient management.

Purpose of the Study:

  • To investigate the association between preprocedural high-sensitivity C-reactive protein (hsCRP) levels and the incidence of CIN.
  • To evaluate the correlation of hsCRP with long-term mortality after CAG.

Main Methods:

  • A cohort of 2133 patients undergoing CAG were enrolled, with preprocedural hsCRP measurements.
  • Patients were followed for a median of 2.3 years to assess CIN incidence and mortality.
  • Statistical analyses, including ROC analysis and adjusted regression models, were employed.

Main Results:

  • The overall incidence of CIN was 2.77%.
  • A significant positive trend was observed between increasing hsCRP quartiles and CIN rates (Q4 >11.3 mg/L had 6.8% incidence).
  • An hsCRP cutoff of 7.3 mg/L demonstrated predictive value for CIN (AUC=0.742), comparable to the Mehran score, and remained an independent predictor (OR=2.83).
  • Elevated hsCRP (>7.3 mg/L) was independently associated with increased long-term mortality (OR=2.04).

Conclusions:

  • Preprocedural hsCRP is a valuable independent predictor of CIN following CAG.
  • Elevated hsCRP levels are associated with increased long-term mortality in patients undergoing CAG.
  • hsCRP may serve as a useful biomarker for risk stratification in patients undergoing coronary angiography.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
682
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
362
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
441
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
687
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K